Correction: Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: A population based-cohort study (PLoS ONE 7, 12 (e50949) DOI: 10.1371/journal.pone.0050949);Trends in Asthma-Related Direct Medical Costs from 2002 to 2007 in British Columbia, Canada: A Population Based-Cohort Study

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Bedouch, Pierrick ^a   Marra, Carlo A ^a   FitzGerald, J Mark ^a,b   Lynd, Larry D ^a   Sadatsafavi, Mohsen ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER COASTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; SHORT ACTING DRUG; THEOPHYLLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CANADA; CHILD; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; DISEASE CONTROL; DRUG COST; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; MEDICAL FEE; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; RETROSPECTIVE STUDY; SCHOOL CHILD; TREND STUDY;

EID: 84870787370     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/annotation/a3275f00-6d75-4430-a0d6-5b4397ba501a     Document Type: Erratum

References (41)

1. Masoli M, Fabian D, Holt S, Beasley R, (2004) The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59: 469-478 doi:10.1111/j.1398-9995.2004.00526.x [doi] ALL526 [pii].
2. Braman SS, (2006) The global burden of asthma. Chest 130: 4S-12S doi:10.1378/chest.130.1_suppl.4S.
3. Gershon AS, Guan J, Wang C, To T, (2010) Trends in asthma prevalence and incidence in Ontario, Canada, 1996-2005: a population study. Am J Epidemiol 172: 728-736 doi:10.1093/aje/kwq189.
4. Aaron SD, Vandemheen KL, Boulet L-P, McIvor RA, Fitzgerald JM, et al. (2008) Overdiagnosis of asthma in obese and nonobese adults. CMAJ 179: 1121-1131 doi:10.1503/cmaj.081332.
5. Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, et al. (2009) Economic burden of asthma: a systematic review. BMC Pulm Med 9: 24 doi:10.1186/1471-2466-9-24.
6. Barnett SBL, Nurmagambetov TA, (2011) Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol 127: 145-152 doi:10.1016/j.jaci.2010.10.020.
7. Anis AH, Lynd LD, Wang XH, King G, Spinelli JJ, et al. (2001) Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ 164: 625-631.
8. GI for A (GINA) (2009) Global Strategy for the Diagnosis and Management of Asthma in Children 5 Years and Younger. Available:http://www.ginasthma.com/Guidelineitem.asp??l1=2&l2=1&intId=1689.
9. Boulet L-P, Becker A, Berube D, Beveridge R, Ernst P, et al. (1999) Canadian asthma consensus report, 1999. CMAJ 161: S1-5.
10. Becker A, Lemière C, Bérubé D, Boulet L-P, Ducharme FM, et al. (2005) Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003. CMAJ 173: S3-11.
11. Lemiere C, Bai T, Balter M, Bayliff C, Becker A, et al. (2004) Adult Asthma Consensus Guidelines update 2003. Can Respir J 11 Suppl A: 9A-18A.
12. Lougheed MD, Lemière C, Dell SD, Ducharme FM, Fitzgerald JM, et al. (2010) Canadian Thoracic Society Asthma Management Continuum-2010 Consensus Summary for children six years of age and over, and adults. Can Respir J 17: 15-24.
13. FitzGerald JM, Boulet LP, McIvor RA, Zimmerman S, Chapman KR, (2006) Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can Respir J 13: 253-259.
14. Klomp H, Lawson JA, Cockcroft DW, Chan BT, Cascagnette P, et al. (2008) Examining asthma quality of care using a population-based approach. CMAJ 178: 1013-1021 doi:10.1503/cmaj.070426.
15. Government of Canada SC (n.d.) Population by sex and age group. Available:http://www40.statcan.gc.ca/l01/cst01/demo10a-eng.htm. Accessed 3 February 2011.
16. BC Ministry of Health (n.d.) Population Data BC. Available:http://www.popdata.bc.ca/data. Accessed 20 November 2011.
17. Ministry of Health (n.d.) PharmaNet. Available:http://www.health.gov.bc.ca/pharmacare/pharmanet/netindex.html. Accessed 29 March 2012.
18. Prosser RJ, Carleton BC, Smith MA, (2008) Identifying persons with treated asthma using administrative data via latent class modelling. Health Serv Res 43: 733-754 doi:HESR775 [pii] 10.1111/j.1475-6773.2007.00775.x [doi].
19. Firoozi F, Lemiere C, Beauchesne MF, Forget A, Blais L, (2007) Development and validation of database indexes of asthma severity and control. Thorax 62: 581-587 doi:thx.2006.061572 [pii] 10.1136/thx.2006.061572 [doi].
20. Chu C, (1994) Resource intensity weighing and case mix grouping: assumptions and implications for health service performance evaluation. Healthc Manage Forum 7: 24-31.
21. Poole B, Robinson S, MacKinnon M, (1998) Resource Intensity Weights and Canadian hospital costs: some preliminary data. Healthc Manage Forum 11: 22-26.
22. Finlayson GN (1999) Hospital Case-Mix Costing Project: Using the Manitoba Management Information System, A First Step. Available:http://www.umanitoba.ca/centres/mchp/reports/reports_97-00/mis.htm.
23. Canadian Institute for Health Information (CIHI) (n.d.) Canadian MIS Database- Hospital Financial Performance Indicators, 1999-2000 to 2008-2009. Methodological Notes. Available:https://secure.cihi.ca/free_products/CMDB_hospita_financial_performance_indicators_meth_notes_2011_en.pdf.
24. Rowe BH, Bota GW, Clark S, Camargo CA, (2007) Comparison of Canadian versus American emergency department visits for acute asthma. Can Respir J 14: 331-337.
25. Lougheed MD, Garvey N, Chapman KR, Cicutto L, Dales R, et al. (2006) The Ontario Asthma Regional Variation Study: Emergency Department Visit Rates and the Relation to Hospitalization Rates. Chest 129: 909-917 doi:10.1378/chest.129.4.909.
26. Awadh Behbehani N, Grunfeld A, FitzGerald JM, (1999) Health care costs associated with acute asthma: a prospective economic analysis. Can Respir J 6: 521-525.
27. Latest release from the Consumer Price Index. Friday, January 25, 2008 (2008). Available:http://www.statcan.ca/english/Subjects/Cpi/cpi-en.htm.
28. Krahn MD, Berka C, Langlois P, Detsky AS, (1996) Direct and indirect costs of asthma in Canada, 1990. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne 154: 821-831.
29. Lougheed MD, Lemiere C, Dell S, Ducharme F, Fitzgerald JM, et al. (2010) Canadian Thoracic Society Asthma Committee commentary on long-acting beta-2 agonist use for asthma in Canada. Can Respir J 17: 57-60.
30. Stafford RS, Ma J, Finkelstein SN, Haver K, Cockburn I, (2003) National trends in asthma visits and asthma pharmacotherapy, 1978-2002. J Allergy Clin Immunol 111: 729-735.
31. Anderson HR, Gupta R, Strachan DP, Limb ES, (2007) 50 years of asthma: UK trends from 1955 to 2004. Thorax 62: 85-90 doi:10.1136/thx.2006.066407.
32. Barcala FJG, Viñas JA, Cuadrado LV, Bourdin A, Dobaño JMA, et al. (2010) Trends in hospital admissions due to asthma in north-west Spain from 1995 to 2007. Allergol Immunopathol (Madr) 38: 254-258 doi:10.1016/j.aller.2009.11.008.
33. Stow PJ, Pilcher D, Wilson J, George C, Bailey M, et al. (2007) Improved outcomes from acute severe asthma in Australian intensive care units (1996 2003). Thorax 62: 842-847 doi:10.1136/thx.2006.075317.
34. Piecoro LP, (2001) Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population. Health Serv Res 36: 357-371.
35. Armstrong EP, Krueger K, Langley PC, (2001) Analysis of Asthma-Related Costs and Patterns of Resource Utilization in a Managed-Care Population. Disease Management & Health Outcomes 9: 161-171.
36. Li J, Xakellis G, Edell E, Angstman G, (1995) Concentration of healthcare costs in asthma. Am J Manag Care 1: 137-140.
37. Sapra S, Nielsen K, Martin BC, (2005) The net cost of asthma to North Carolina Medicaid and the influence of comorbidities that drive asthma costs. J Asthma 42: 469-477.
38. Gershon AS, Wang C, Guan J, To T, (2010) Burden of comorbidity in individuals with asthma. Thorax 65: 612-618 doi:10.1136/thx.2009.131078.
39. Gendo K, Sullivan SD, Lozano P, Finkelstein JA, Fuhlbrigge A, et al. (2003) Resource costs for asthma-related care among pediatric patients in managed care. Ann Allergy Asthma Immunol 91: 251-257 doi:10.1016/S1081-1206(10)63526-0.
40. Stock S, Redaelli M, Luengen M, Wendland G, Civello D, et al. (2005) Asthma: prevalence and cost of illness. Eur Respir J 25: 47-53 doi:10.1183/09031936.04.00116203.
41. Ungar WJ, Coyte PC, (2001) Prospective study of the patient-level cost of asthma care in children. Pediatr Pulmonol 32: 101-108 doi:10.1002/ppul.1095 [pii].